SCHEMBL30726401

SCHEMBL30726401

CC(C)(C)OC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(C(N)=O)CC1

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27039441 1.00 IRAK4 (0.65) IRAK4
SCHEMBL21069625 0.94 IRAK4 (0.67) IRAK4
SCHEMBL34464127 0.94 IRAK4 (0.67) IRAK4
SCHEMBL30726296 0.91 IRAK4 (0.65) IRAK4
SCHEMBL27039602 0.91 IRAK4 (0.65) IRAK4
SCHEMBL27039560 0.88 IRAK4 (0.69) IRAK4
SCHEMBL30726293 0.88 IRAK4 (0.69) IRAK4
SCHEMBL23806213 0.82 IRAK4 (0.73) IRAK4
SCHEMBL21070032 0.81 IRAK4 (0.71) IRAK4
SCHEMBL30726378 0.81 IRAK4 (0.71) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4558495-A1 HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 Bristol-Myers Squibb Company (US) 2025-05-28 EP disclosed
WO-2024020084-A1 HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 BRISTOL-MYERS SQUIBB COMPANY (US) 2024-01-25 WO disclosed